| Literature DB >> 34188422 |
Sergio Haimovich1, Tanvir Tanvir2.
Abstract
Postmenopausal bleeding (PMB) is a common cause for a gynecological visit. Endometrial cancer risk varies from 3% to 25% in women with PMB. There is a significant concern of malignancy of the endometrium and the endocervical canal by a physician in postmenopausal women, and hence, most prefer operating room hysteroscopies with dilation and curettage (D & C) compared to in-office procedures. With increased availablility of miniaturized instruments such as mini- resectoscope and tissue removal systems, there is high likelihood of blind D & C being replaced by hysteroscopic- guided targetted biopsy or visual D & C. The cost-effectiveness of office hysteroscopy is also well demonstrated. In December 2020, an electronic search was performed of PubMed, MEDLINE, and Cochrane Library to look for articles on office hysteroscopic biopsy techniques in postmenopausal women from 2010 to 2020. Relevant studies were included where various office hysteroscopic techniques are used for endometrial sampling in PMB. Studies with 5 Fr scissors, biopsy forceps, crocodile forceps, cup forceps, bipolar electrode, in-office tissue removal system (morcellator), flexible hysteroscope, and mini-resectoscope were included. Standard reference was used as an adequate endometrial sample for histology. The objective of this review is to explore the current evidence on different office hysteroscopic techniques available for endometrial tissue sampling in PMB. RESEARCH QUESTION: What are the different available in - office hysteroscopy techniques for obtaining endometrial biopsy? CLINICAL IMPORTANCE: Understanding the adequacy of an endometrial tissue sample obtained by different in - office hysteroscopy techniques and their accuracy by histology. Copyright:Entities:
Keywords: Office hysteroscopy techniques; postmenopausal bleeding; targeted biopsy
Year: 2021 PMID: 34188422 PMCID: PMC8189338 DOI: 10.4103/jmh.jmh_42_21
Source DB: PubMed Journal: J Midlife Health ISSN: 0976-7800
Figure 1(A) 5 mm office hysteroscope; (B) 5 Fr tenaculum; (C) 5 Fr alligator forceps; (D) 5 Fr bipolar electrode; (E) 5 Fr scissors. 2: (A) 14.9 Fr gubbini resectoscope; (B) reusalble bipolar loop large; (C) reusable knife; (D) reusable loop electrode straight. 3: (A) TruClear™ handpiece; (B) TruClear™ Elite 6 mm hysteroscope; (C and D) TruClear™ soft tissue shaver mini
Figure 2Grasp technique. 1: Introduction of the alligator forceps; 2: Jaws are opened; 3: Forceps is advanced up to 0.5–1 cm; 4: Tissue is brought out along with the instrument
Figure 3Biopsy using a scissors. 1: Introduction of the scissors; 2: Jaws are opened; 3: Precise cuts are made parallel to the tissue and tissue brought out with an alligator forceps
Sensitivity, specificity and diagnostic accuracy of hysteroscopic-guided biopsy for endometrial hyperplasia and endometrial cancer
| Author | Endometrial sampling method | Biopsy technique | Type of study | Time frame | Sensitivity (%) | Specificity (%) | Diagnostic accuracy (%) | |
|---|---|---|---|---|---|---|---|---|
| Clark | Hysteroscopy | Various | Systemic review | 26,346 | 2002 | 86.4 | 99.2 | - |
| Garuti | Hysteroscopy | Targeted biopsy | Retrospective multicenter Italian study | 984 | 2012-2018 | 76.2 | 52.8 | 75.3 |
| Garuti | Hysteroscopy | Hysteroscopic view for diagnosing endometrial cancer | Retrospective multicenter Italian study | 984 | 2012-2018 | 54.2 | 47.2 | 54 |
| Ianieri | Hysteroscopy– | Hysteroscopic risk scoring based the hysteroscopic view | Retrospective study | 435 | - | 95.4 | 98.2 | - |
| Di Spiezio Sardo | Hysteroscopy | Grasp technique | Retrospective cross-sectional study | 129 | 2015-2018 | 100 (for G1 endometrioid cancer) | 97 (for G1 endometrioid cancer) | 100 |
| De Franciscis | Hysteroscopy | Punch or grasp biopsy | Prospective cohort study | 92 | 2018 | 97.9 for EH 100 EC | 39.5 for EH 100 for EC | 100 for EC |
| Sarvi | Hysteroscopy | Targeted biopsy | Cross-sectional study | 67 | 2014-15 | 100 | 97 | - |
| Giannella | Hysteroscopy biopsy versus hysteroscopic resection versus D and C | Targeted biopsy versus resection versus D and C | Retrospective observational study | 75 | 2000-2017 | - | - | 19.5% risk of underestimation of endometrial cancer in a diagnosed case of atypical endometrial hyperplasia, targeted biopsy whereas hysteroscopic resection is only 11.6% (lowest) and D and C is 35.3% (highest)? |
| Omar | Hysteroscopy | Targeted biopsy | Multicenter retrospective study | 189 | 2014-16 | 85.4 | 96.1 | - |
| Rosenblatt | Hysteroscopy | Myosure lite | Prospective pilot study ( | 7 | 2015-2016 | - | - | 100 |
EC: Endometrial cancer; EH: Endometrial hyperplasia; ? Therefore we understand that hysteroscopic resection has the highest rate of detection for endometrial cancer and D & C has the lowest
Figure 4Biopsy with TruClear™ Elite using a soft tissue shaver mini